Skip to content
music — Pets — Lifestyle — Home-and-garden — Eye-health — Skin-care — Cance — Weight-management — Digestive-health — Womens-health — Cars — Shopping — Wealth-management — Finance — Chronic-diseases — Movies-and-tv — travel — Personal-finance — Parenting — Sexual-health — Fitness-and-exercise — Workplace-wellness — Nutrition — Entertainment — Medicare — Books — Medical-conditions — Cybersecurity — Space-and-astronomy — Technology — Industry — Science — Skin-conditions — Social-media — Autoimmune-disorders — Investing — Gadgets — Mens-health — Cbd — Health-and-wellness — Food-and-drink — Aging — Sleep — Business — Climate-change — Hearing — Mental-health — Relationships — Fashion-and-beauty

In a groundbreaking move, American physicians employ gene editing to save a child afflicted by a life-threatening ailment.

Rare condition CPS1 deficiency, only present in approximately 1 out of 1.3 million individuals, discovered in newborn boy.

,   and  Administrator
4 min read
Rare Disorder CPS1 Deficiency Diagnosed in Newborn; Prevalence Stands at Approximately 1 in 1.3...
Rare Disorder CPS1 Deficiency Diagnosed in Newborn; Prevalence Stands at Approximately 1 in 1.3 Million Individuals.

In a groundbreaking move, American physicians employ gene editing to save a child afflicted by a life-threatening ailment.

A groundbreaking DNA editing procedure has saved the life of an american baby boy, marking a significant leap in the medical world. The little hero, affectionately known as KJ, was born with a rare and potentially fatal genetic disorder, CPS1 deficiency, a condition affecting approximately 1 in 1.3 million individuals.

This unique case, reported by The Guardian, unfolded at the Children's Hospital of Philadelphia, where a team of doctors crafted a custom treatment for the newborn within six months of his birth.

CPS1 deficiency is characterized by the absence of a vital liver enzyme that converts ammonia from protein breakdown into urea for excretion. The accumulation of ammonia can damage the liver and other organs, including the brain, making it a life-threatening condition.

To combat this, the doctors resorted to a revolutionary gene-editing approach, previously unattempted, to correct the mutations in KJ's genes. They then used base editing, a proven method to rewrite the DNA code one letter at a time, to deliver the correction. To facilitate the process, they employed tiny fat particles, known as nanoparticles, to ferry the edited genes into the liver.

In February 2024, KJ received the first dose of the medication via infusion, followed by two additional doses in March and April. Dr Rebecca Ahrens-Nicklas, senior physician at the hospital, credited "years and years of progress" in gene editing for making this breakthrough possible.

Though KJ is just one patient, Dr Ahrens-Nicklas expressed optimism, stating, "We hope he is the first of many to benefit."

Professor Kiran Musunuru from the University of Pennsylvania lauded the development, saying, "The promise of gene therapy we've heard about for decades is coming to fruition, and it's going to utterly transform the way we approach medicine."

As for KJ, he's doing well following his treatment, offering hope and a potential new era in medicine for those battling rare genetic disorders. In the broader context, this development paves the way for personalized gene editing as a viable solution for treating various genetic disorders, potentially lessening the need for more invasive procedures like organ transplants. Moving forward, rapid progress in gene editing technology could be instrumental in creating quick and effective personalized treatments for life-threatening conditions.

[1] New England Journal of Medicine - [Article Title][2] The Guardian - [Article Title][3] Penn Medicine News - [Article Title]

  1. The medical world has witnessed a major milestone with a groundbreaking DNA editing procedure saving an American baby boy's life.
  2. Known affectionately as KJ, this young hero was born with a rare and potentially fatal genetic disorder, CPS1 deficiency.
  3. This condition affects approximately 1 in 1.3 million individuals and is characterized by the absence of a vital liver enzyme.
  4. The team of doctors at the Children's Hospital of Philadelphia developed a custom treatment for KJ within six months of his birth.
  5. CPS1 deficiency can cause the accumulation of ammonia, which can damage the liver and other organs, including the brain.
  6. To combat this, the doctors employed a revolutionary gene-editing approach to correct the mutations in KJ's genes.
  7. They used base editing, a proven method to rewrite the DNA code one letter at a time, to deliver the correction.
  8. Tiny fat particles, known as nanoparticles, were used to ferry the edited genes into KJ's liver.
  9. In February 2024, KJ received the first dose of the medication via infusion.
  10. Dr Rebecca Ahrens-Nicklas, senior physician at the hospital, credited "years and years of progress" in gene editing for making this breakthrough possible.
  11. KJ is doing well following his treatment, offering hope and a potential new era in medicine for those battling rare genetic disorders.
  12. Dr Ahrens-Nicklas expressed optimism, stating, "We hope he is the first of many to benefit."
  13. Professor Kiran Musunuru from the University of Pennsylvania lauded the development, saying, "The promise of gene therapy we've heard about for decades is coming to fruition."
  14. This development paves the way for personalized gene editing as a viable solution for treating various genetic disorders.
  15. It could potentially lessen the need for more invasive procedures like organ transplants.
  16. Rapid progress in gene editing technology could be instrumental in creating quick and effective personalized treatments for life-threatening conditions.
  17. The New England Journal of Medicine published an article detailing this groundbreaking procedure.
  18. Another article about this case was reported by The Guardian.
  19. Penn Medicine News also covered the story, highlighting the innovative approach taken by the doctors.
  20. Gene editing technology is expected to bring significant changes in the medical industry.
  21. The advancement in gene editing could revolutionize the healthcare and wellness sector, including workplace wellness programs.
  22. It could also bring about a new era in managing chronic diseases such as cancer, respiratory conditions, and digestive health issues.
  23. Eye health, hearing, and skin care could also benefit from advancements in gene editing technology.
  24. Mental health, men's health, and women's health could all see improvements due to gene editing advancements.
  25. Fitness and exercise, sexual health, and autoimmune disorders could also be addressed more effectively with advancements in gene editing.
  26. Climate change and environmental science could even see the application of gene editing technology in the future.
  27. However, the use of gene editing technology comes with its own set of ethical considerations and potential risks, such as neurological disorders.
  28. As with any technological advancement, the industry, finance, and overall economy could be significantly impacted by the rapid progress in gene editing, affecting areas like data and cloud computing, artificial intelligence, and even personal finance, home and garden, business, and investing.

Read also:

    Related

    Latest